1. Gilchrest BA. Molecular aspects of tanning. J Invest Dermatol. 2011; 131:E14–E17.
Article
2. Hodgson C. Senile lentigo. Arch Dermatol. 1963; 87:197–207.
Article
3. Kang HY, Ortonne JP. What should be considered in treatment of melasma. Ann Dermatol. 2010; 22:373–378.
Article
4. Finch PW, Rubin JS, Miki T, Ron D, Aaronson SA. Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth. Science. 1989; 245:752–755.
Article
5. Chen N, Hu Y, Li WH, Eisinger M, Seiberg M, Lin CB. The role of keratinocyte growth factor in melanogenesis: a possible mechanism for the initiation of solar lentigines. Exp Dermatol. 2010; 19:865–872.
Article
6. Lin CB, Hu Y, Rossetti D, Chen N, David C, Slominski A, et al. Immuno-histochemical evaluation of solar lentigines: The association of KGF/KGFR and other factors with lesion development. J Dermatol Sci. 2010; 59:91–97.
Article
7. Hirobe T, Hasegawa K, Furuya R, Fujiwara R, Sato K. Effects of fibroblast-derived factors on the proliferation and differentiation of human melanocytes in culture. J Dermatol Sci. 2013; 71:45–57.
Article
8. Iriyama S, Ono T, Aoki H, Amano S. Hyperpigmentation in human solar lentigo is promoted by heparanase-induced loss of heparan sulfate chains at the dermal-epidermal junction. J Dermatol Sci. 2011; 64:223–228.
9. Lee DJ, Park KC, Ortonne JP, Kang HY. Pendulous melanocytes: a characteristic feature of melasma and how it may occur. Br J Dermatol. 2012; 166:684–686.
Article
10. Torres-Álvarez B, Mesa-Garza IG, Castanedo-Cázares JP, Fuentes-Ahumada C, Oros-Ovalle C, Navarrete-Solis J, et al. Histochemical and immunohistochemical study in melasma: evidence of damage in the basal membrane. Am J Dermatopathol. 2011; 33:291–295.
Article